| Year |
Title |
Altmetric |
| 2023
|
Drug Permeability: From the Blood–Brain Barrier to the Peripheral Nerve Barriers.
Advanced Therapeutics.
2023
|
|
| 2022
|
Pro-inflammatory cytokines and leukocyte integrins associated with chronic neuropathic pain in traumatic and inflammatory neuropathies: Initial observations and hypotheses.
Frontiers in Immunology.
13.
2022
|
|
| 2022
|
Disruption of Endosomal Sorting in Schwann Cells Leads to Defective Myelination and Endosomal Abnormalities Observed in Charcot-Marie-Tooth Disease
2022
|
|
| 2022
|
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
Neurology.
98:E376-E389.
2022
|
|
| 2022
|
A Novel Dynamin 2 Mutation Causing Dominant Intermediate Charcot-Marie-Tooth Neuropathy: Case Report.
Journal of Investigative Medicine High Impact Case Reports.
10.
2022
|
|
| 2021
|
Glial derived neurotrophic factor: a sufficient essential molecular regulator of mammalian blood-nerve barrier tight junction formation.
Neural Regeneration Research.
16:1417-1418.
2021
|
|
| 2021
|
Hirayama Disease: An Important Cause of Focal Hand Weakness in Young Adults.
Journal of Investigative Medicine High Impact Case Reports.
9.
2021
|
|
| 2020
|
Clinical features of LRP4/agrin-antibody–positive myasthenia gravis: A multicenter study.
Muscle and Nerve.
62:333-343.
2020
|
|
| 2020
|
Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review.
Journal of the Peripheral Nervous System.
25:230-237.
2020
|
|
| 2020
|
Biology of the human blood-nerve barrier in health and disease.
Experimental Neurology.
328.
2020
|
|
| 2020
|
Fibulin-5 mutation featuring Charcot-Marie-Tooth disease, joint hyperlaxity, and scoliosis
2020
|
|
| 2019
|
In situ molecular characterization of endoneurial microvessels that form the blood-nerve barrier in normal human adult peripheral nerves.
Journal of the Peripheral Nervous System.
24:195-206.
2019
|
|
| 2019
|
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.
Journal of the Peripheral Nervous System.
24:48-55.
2019
|
|
| 2019
|
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.
Journal of the Peripheral Nervous System.
24:72-79.
2019
|
|
| 2018
|
Immunotherapy of Guillain-Barré syndrome.
Human Vaccines and Immunotherapeutics.
14:2568-2579.
2018
|
|
| 2018
|
GDNF enhances human blood-nerve barrier function in vitro via MAPK signaling pathways.
Tissue Barriers.
6:1-22.
2018
|
|
| 2018
|
Intravenous versus subcutaneous immunoglobulin – Authors' reply.
Lancet Neurology.
17:393-394.
2018
|
|
| 2018
|
Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy.
Tissue Barriers.
6:1-22.
2018
|
|
| 2018
|
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Neurology.
17:35-46.
2018
|
|
| 2017
|
The Human Blood-Nerve Barrier Transcriptome.
Scientific Reports.
7.
2017
|
|
| 2017
|
Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
Experimental Neurology.
292:35-45.
2017
|
|
| 2017
|
A novel method for measuring hydraulic conductivity at the human blood-nerve barrier in vitro.
Microvascular Research.
109:1-6.
2017
|
|
| 2016
|
"Small Blood Vessels: Big Health Problems?": Scientific Recommendations of the National Institutes of Health Workshop.
Journal of the American Heart Association.
5.
2016
|
|
| 2016
|
The pathogenic relevance of αM-integrin in Guillain–Barré syndrome.
Acta Neuropathologica.
132:739-752.
2016
|
|
| 2016
|
Acute myofascitis as a manifestation of chronic graft-versus-host disease.
Muscle and Nerve.
53:327-329.
2016
|
|
| 2016
|
Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation.
Journal of Neuroinflammation.
13.
2016
|
|
| 2015
|
Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.
Acta Neuropathologica.
130:445-468.
2015
|
|
| 2015
|
Osteoblasts Have a Neural Origin in Heterotopic Ossification.
Clinical Orthopaedics and Related Research.
473:2790-2806.
2015
|
|
| 2014
|
VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy..
Molecular Therapy.
22:1353-1363.
2014
|
|
| 2014
|
CCR2 Gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
PLoS One.
9.
2014
|
|
| 2014
|
VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy.
Molecular Therapy.
22:1353-1363.
2014
|
|
| 2013
|
A man with small vessel vasculitis presenting with brachial diplegia, multiple cranial mononeuropathies and severe orthostatic hypotension in diabetes mellitus: A case report.
Journal of Medical Case Reports.
7.
2013
|
|
| 2013
|
A case of severe chronic progressive axonal polyradiculoneuropathy temporally associated with anti-CV2/CRMP5 antibodies.
Journal of Clinical Neuromuscular Disease.
15:13-18.
2013
|
|
| 2013
|
The role of chemokines in guillain-barré syndrome.
Muscle and Nerve.
48:320-330.
2013
|
|
| 2013
|
VEGF-A165 Potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis, and wound healing in vitro.
Cellular and Molecular Neurobiology.
33:789-801.
2013
|
|
| 2013
|
An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies.
Cellular and Molecular Neurobiology.
33:175-186.
2013
|
|
| 2013
|
Chemokine-dependent signaling pathways in the peripheral nervous system.
Methods in Molecular Biology.
1013:17-30.
2013
|
|
| 2013
|
The molecular and biophysical characterization of the human blood-nerve barrier: Current concepts.
Journal of Vascular Research.
50:289-303.
2013
|
|
| 2012
|
Translational strategies in peripheral neuroinflammation and neurovascular repair.
Translational Neuroscience.
3:373-383.
2012
|
|
| 2012
|
α Mβ 2-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro.
Journal of Cellular Physiology.
227:3857-3875.
2012
|
|
| 2012
|
Subacute brachial diplegia associated with west nile virus myelitis.
Muscle and Nerve.
45:900-904.
2012
|
|
| 2012
|
GDNF restores human blood-nerve barrier function via RET tyrosine kinase-mediated cytoskeletal reorganization.
Microvascular Research.
83:298-310.
2012
|
|
| 2012
|
Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model.
Journal of the Peripheral Nervous System.
17:53-61.
2012
|
|
| 2012
|
Transient brown adipocyte-like cells derive from peripheral nerve progenitors in response to bone morphogenetic protein 2.
Stem Cells Translational Medicine.
1:874-885.
2012
|
|
| 2011
|
Chemokine receptors as specific anti-inflammatory targets in peripheral nerves
2011
|
|
| 2010
|
Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: Technical aspects and normative data.
Muscle and Nerve.
41:850-856.
2010
|
|
| 2010
|
Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
Journal of Neuroimmunology.
219:54-63.
2010
|
|
| 2010
|
Development and characterization of a novel human in vitro blood-nerve barrier model using primary endoneurial endothelial cells.
Journal of Neuropathology and Experimental Neurology.
69:82-97.
2010
|
|
| 2010
|
Selective expression and cellular localization of pro-inflammatory chemokine ligand/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
Neuropathology and Applied Neurobiology.
36:388-398.
2010
|
|
| 2009
|
Dynamic properties of eye movements in mitochondrial chronic progressive external ophthalmoplegia.
Eye.
23:382-388.
2009
|
|
| 2008
|
Interferon-α-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient.
European Journal of Gastroenterology and Hepatology.
20:1110-1114.
2008
|
|
| 2008
|
Predictors of Clinical Outcome and Mortality in Vertebrobasilar Dolichoectasia Diagnosed by Magnetic Resonance Angiography.
Journal of Stroke and Cerebrovascular Diseases.
17:388-393.
2008
|
|
| 2008
|
Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration.
Journal of Immunology Research.
2008.
2008
|
|
| 2007
|
Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic.
Journal of the Neurological Sciences.
260:267-270.
2007
|
|
| 2007
|
Inflammatory cell migration into the central nervous system: A few new twists on an old tale.
Brain Pathology.
17:243-250.
2007
|
|
| 2007
|
"Doing the locomotion" with the multistep paradigm.
Blood.
109:1342-1343.
2007
|
|
| 2006
|
CCR5 expression on monocytes and T cells: Modulation by transmigration across the blood-brain barrier in vitro.
Cellular Immunology.
243:19-29.
2006
|
|
| 2006
|
Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.
Journal of Neuroimmunology.
179:132-144.
2006
|
|
| 2006
|
Electrodiagnostic criteria for carpal tunnel syndrome in axonal polyneuropathy.
Muscle and Nerve.
33:747-752.
2006
|
|
| 2006
|
Modulating CCR2 and CCL2 at the blood-brain barrier: Relevance for multiple sclerosis pathogenesis
2006
|
|
| 2006
|
The expression and function of chemokines involved in CNS inflammation.
Trends in Pharmacological Sciences.
27:48-55.
2006
|
|
| 2005
|
Adult polyglucosan body disease: A case report of a manifesting heterozygote.
Muscle and Nerve.
32:675-681.
2005
|
|
| 2005
|
Complete innervation of extensor digitorum brevis by accessory peroneal nerve.
Neuromuscular Disorders.
15:562-564.
2005
|
|
| 2005
|
Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta [1] (multiple letters).
Neurology.
65:1681-1682.
2005
|
|
| 2004
|
Clinical and radiological features of symptomatic cerebral perfusion failure due to carotid artery occlusion surgically corrected by extracranial-intracranial bypass surgery [2].
Journal of Neurology.
251:613-616.
2004
|
|
| 2004
|
Asymptomatic middle cerebral artery stenosis diagnosed by magnetic resonance angiography.
2004
|
|
| 2004
|
Transverse myelitis associated with Acinetobacter baumanii intrathecal pump catheter-related infection. Where was the source of the infection? [1] (multiple letters).
Regional Anesthesia and Pain Medicine.
29:503-504.
2004
|
|
| 2004
|
Vertebrobasilar dolichoectasia diagnosed by magnetic resonance angiography and risk of stroke and death: A cohort study.
Journal of Neurology, Neurosurgery and Psychiatry.
75:22-26.
2004
|
|
| 2003
|
Adverse Reactions to Mirtazapine are Unlikely to be Serotonin Toxicity [1].
Clinical Neuropharmacology.
26:287-290.
2003
|
|
| 2003
|
Mirtazapine-induced serotonin syndrome.
Clinical Neuropharmacology.
26:54-57.
2003
|
|
| 2003
|
Ketamine for refractory status epilepticus : A case of possible ketamine-induced neurotoxicity.
Epilepsy and Behavior.
4:70-75.
2003
|
|
| 2003
|
Transverse myelitis associated with Acinetobacter baumanii intrathecal pump catheter-related infection.
Regional Anesthesia and Pain Medicine.
28:470-474.
2003
|
|
| 2002
|
Rectus sheath hematoma complicating percutaneous endoscopic gastrostomy.
Surgical Laparoscopy, Endoscopy and Percutaneous Techniques.
12:430-432.
2002
|
|
| 2002
|
Cervicomedullary junction compression caused by vertebral artery dolichoectasia and requiring surgical treatment.
Journal of Neurosurgery.
96:140-143.
2002
|
|
| 2002
|
Otalgia as the sole presenting manifestation of subdural hematoma
2002
|
|
| 2002
|
Recurrent transient ischemic attacks as the initial presenting manifestation of type A aortic dissection
2002
|
|
| 2001
|
The preferential involvement of extraocular muscles by myasthenia gravis.
Neuro-Ophthalmology.
25:219-228.
2001
|
|
| 2001
|
Amaurosis fugax associated with phencyclidine inhalation.
European Neurology.
46:98-99.
2001
|
|
| 2001
|
Acute motor-sensory axonal neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies
2001
|
|
